EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ANTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2010. Start Trial.
Date Value
March 31, 2018 -1.70
December 31, 2017 -3.31
September 30, 2017 -5.46
June 30, 2017 -9.76
March 31, 2017 -12.59
December 31, 2016 -12.88
September 30, 2016 -11.44
June 30, 2016 -8.88
March 31, 2016 -8.08
December 31, 2015 -8.00
September 30, 2015 -9.12
June 30, 2015 -9.28
March 31, 2015 -10.00
December 31, 2014 -10.88
September 30, 2014 -12.16
June 30, 2014 -12.08
March 31, 2014 -12.80
Date Value
December 31, 2013 -13.52
September 30, 2013 -67.28
June 30, 2013 -75.76
March 31, 2013 -99.84
December 31, 2012 -128.64
September 30, 2012 -120.96
June 30, 2012 -148.48
March 31, 2012 -163.20
December 31, 2011 -166.40
September 30, 2011 -142.08
June 30, 2011 -126.72
March 31, 2011 -107.52
December 31, 2010 -124.80
September 30, 2010 -99.20
June 30, 2010 -76.16
March 31, 2010 -53.12

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.196
Alnylam Pharmaceuticals, Inc. 4.209
Savara, Inc. -0.5584
Vericel Corp. 0.4091
Biogen, Inc. 9.318